mayo clinic glp 1 oral solution GLP-1s have continued to dominate the headlines. But are they everything we hoped for?⁣ ⁣ On this podcast episode of Obesity Week: Mayo Clinic study

It is a non-invasive, effective, precise treatment, leading to long-lasting results

In addition to its potential influence on sleep patterns, DSIP appears to influence levels of corticotropin, inhibit the production of somatostatin, reduce stress hormone secretion, maintain normal blood pressure, alter sleep patterns and also may impact pain perception

This correlation appears decades before the onset of cognitive symptoms

Plasma acylcarnitine profiles prior to riboflavin supplementation was suggestive of multiple acyl-CoA dehydrogenase defect (MADD) [22]

The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe